Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Retatrutide for Sale > Retatrutide 99% pure Peptide powder for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report
Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report buy - large image1
Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report buy - image1
Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report buy - image2
Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report buy - image3
Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report buy - image4
Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report buy - image5
Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report buy - image6

Retatrutide 99% pure Peptide powder for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report

TDS 7020 Inquiries

Unit Price:

$55-70/UNIT FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

KS

Packaging:

10vials/box,5mg,10mg,15mg,20mg,30mg,ect

Price valid (until):

2028-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
1 days
Qualification:
Main Products:

GLP-1,semaglutide,Retatrutide,Tirzepatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    Sale Manager:Lisa

    WhatsApp: +86-15031947596

    Email:Lisa@xtkstech.com

    Sincerely look forward to your inquiries about our products.


       Product Detail  


    Retatrutide (Rivetide)  is the world's first long-acting peptide substance with three target points (GLP-1/GIP/GCGR) to enter the phase III clinical trial stage. It mainly targets various metabolic diseases such as obesity, overweight, type 2 diabetes, and metabolic-related fatty liver disease. Currently, it has not been approved for sale in any country worldwide. This product can effectively inhibit appetite, increase energy consumption of the body, improve blood sugar control and lipid metabolism, and significantly reduce liver fat accumulation by simultaneously acting on the three key metabolic receptors. Its overall effect is significantly better than that of current single-target and dual-target similar products on the market. Clinical data shows that at the highest dose, the average weight loss ratio over 68 weeks can reach 28.7%. It also performs well in reducing glycated hemoglobin and improving liver function indicators. The overall safety is controllable, and the main adverse reactions are mild to moderate and transient gastrointestinal reactions. It has the potential to become a new-generation blockbuster metabolic drug.

    Items Specifications
    roduct Name Retatrutide
    CAS No. 2381089-83-2
    Purity >99.0%
    Grade Pharmacy Grade
    Application Weight loss
    Storage Cool Dry Place

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 1

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 2

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 3 Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 4


       Function  


    Weight management : Ritaglutide is being developed for weight loss treatment. It can stimulate multiple targets, suppress appetite, increase satiety, reduce food intake, and help patients significantly lose weight.
    Metabolic improvement : Not only can it help obese patients lose weight, but it can also improve metabolic problems related to obesity, such as hypertension, hyperlipidemia, etc.
    Blood sugar control : Ritaglutide can enhance inhibit glucagon secretion by stimulating GLP-1 and other receptors, thereby effectively reducing blood sugar levels. Therefore, it has good blood sugar control effect on type 2 diabetes patients.
    Multi effect mechanism : Ritaglutide activates multiple receptors (GLP-1, GIP, and glucagon receptor), which may have a more significant effect on blood glucose control and a more comprehensive metabolic regulatory ability compared to traditional single target GLP-1 agonists.

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 5


      Company  introduction  


    Hongbai Technology Co., Ltd.    is a branch of Changsha Dolo Technology Co., Ltd.,which is a pioneering force in the biotechnology sector.

    At the core of our operations is the unwavering commitment to our guiding principles : "Quality First, Service Supreme."Our mission is to spearhead advancements in biotechnology by consistently upholding the highest standards of quality and service. Through innovation and excellence, we aim to contribute to the betterment of global health and well-being.

    Our primary focus encompasses a range of products , including weight loss peptides, cosmetic peptides, and customized peptides. Notable among our weight loss peptide offerings are Tirzepatide, Retatrutide, and others.Provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the Clients.We have professional sales team , focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market, our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.

    With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers .

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 6

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 7

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 8

    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 9



    Why choose us


    1.We have more than 10 years of experience in the field of chemical industry, the company's products are exported to more than 60 countries overseas, of which 80% are exported to Europe and America, 20% are exported to Southeast Asia, the Middle East, South Africa and other regions.

    2.We have our own production plant and R & D center, to provide customers with technical support, product customization, free recipes and other whole industry chain services. Support full video inspection, testing, global delivery package.

    3.We accept sample orders for testing, after purchasing products from our factory, we have a professional technical team and after-sales team to serve you and solve all your future problems. 100% quality assurance, 100% safe delivery.


    Type of shipping


    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 10


    Payment method


    Shop Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report-Detailed Image 11


      Q&A  


    Q1: Can I get a sample before placing an order?

    A1: Yes, we can provide samples, you only need to pay the shipping fee and sample fee.

    Q2: Why should you buy from us instead of other suppliers?

    A2: Because we are a factory, we can provide lower prices and guaranteed quality. We have extensive experience in domestic and foreign trade and provide services in an honest, timely and efficient manner.

    Q3: How to place an order for each product?

    A3: Please send us an inquiry and let us know your requirements; we will send you a complete quotation including freight, confirm the order and send payment/deposit, we will arrange production or delivery of the goods after receiving the bank receipt.

    Q4: Do you have stock?
    A4: We understand most customers prefer stock, so we'll try to keep stock for most products. However, for some rare products, we won't keep stock and it needs time to synthesize.

    Welcome to be our distinguished customer,please do not hesitate to contact us!

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • Retatrutide 99% pure Peptide powder  for Body building cas 2381089-83-2 Weight Loss Peptide with COA Report Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Other Chemical Drugs

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,semaglutide,Retatrutide,Tirzepatide

    Location:

    Room 2012, No. 6-143, Section 2, Shanghai Road, Guta District, Jinzhou City, Liaoning Province

    Payment Terms:

    TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    1 days

    Year of Establishment:

    2024

  • Inquiry History
    7020 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.